Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades1,228
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions1
HIK
Media
HIK Company
Research
HIK Company
Timeline1
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
1,471.00
11.00 (0.75%)
Bid:
1,475.00
Ask:
1,477.00
Spread:
2.00 (0.136%)
Market Cap:
£3.13b
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
2 days ago
US Supreme Court backs generic drugmaker in 'skinny label' patent case
* Case involved Amarin's cardiovascular drug Vascepa
2 days ago
US Supreme Court backs generic drugmaker in 'skinny label' patent case
* Case involved Amarin's cardiovascular drug Vascepa
5 May 2026
LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities
(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:
29 Apr 2026
UPDATE 1-US Supreme Court to hear 'skinny label' patent fight involving Amarin
* Amarin Pharma sued British generic drug maker Hikma
28 Apr 2026
Pfizer secures deals to keep heart drug free of generic rivals until 2031
April 28 (Reuters) - Pfizer said on Tuesday it has settled patent disputes with three generic drugmakers over its blockbuster heart drug Vyndamax, ...
23 Apr 2026
UK's Hikma Pharma backs outlook on faith in demand, managing Iran war costs
* Says Middle East demand robust, maintaining sufficient inventory
23 Apr 2026
Hikma Pharmaceuticals backs outlook as Middle East demand stays robust
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated full year guidance following an "encouraging" start to the year, with all three bus...
Follow the stocks
